Trial Profile
Impact of Sitagliptin on Diabetes Mellitus in Japanese elderly patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2017
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms SMILE
- 19 May 2017 Status changed from active, no longer recruiting to completed.
- 13 Dec 2012 New trial record